Menu
Not yet recruiting NCT07648199

Morphological and Mechanical Assessment in the Achilles Tendon After Radiofrequency Stimulation in Runners

No phase Interventional Achilles Tendon Injury Achilles Tendon

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 448 kHz capacitive resistive monopolar radiofrequency.
Who it may be relevant to
Registry conditions: Achilles Tendon Injury, Achilles Tendon. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Morphological and Mechanical Changes in the Achilles Tendon After the Application of INDIBA® Therapy in Healthy Runners: A Pre-post Quasi-experimental Study

Overview

448 kHz capacitive-resistive monopolar radiofrequency is an emerging physiotherapy technique whose usefulness and clinical relevance still need to be investigated. This study is a pre-post quasi-experimental study in which several variables will be measured before and immediately after 448 kHz capacitive resistive monopolar radiofrequency. It aims to analyze the morphological and mechanical changes in the Achilles tendon following the intervention in healthy runners.

Detailed description

The Achilles tendon is fundamental to running biomechanics, and its performance directly affects athletic performance and injury prevention. 448 kHz capacitive resistive monopolar radiofrequency has demonstrated effects on vascularization, recovery, and elasticity of musculoskeletal tissues. However, there are no studies that comprehensively evaluate the morphological, mechanical, and functional changes in the Achilles tendón in healthy runners after the application of this technique. The investigators expect the intervention to induce short-term morphological and mechanical changes in the Achilles tendon, providing further insight into the potential of this technique as a preventive tool.

Interventions

  • Device 448 kHz capacitive resistive monopolar radiofrequency
    The procedure will consist of a 20-minute radiofrequency session on the Achilles tendon, applying 10 minutes in capacitive mode and 10 minutes in resistive mode. The device has a maximum peak power of 200 W and 450 V. Both modes will be administered as a hyperthermia dose, adjusted according to the patient's subjective perception of heat, with a target of 8/10. The application will be performed longitudinally on the Achilles tendon, from proximal to distal and from distal to proximal, measuring

Primary outcome measures

  • Achilles tendon thickness (mm) measured by B-mode ultrasound [Time frame: 1 hour]
  • Elastography in Achilles tendon [Time frame: 1 hour]
Secondary outcome measures (2)
  • Plantar flexion strength [Time frame: 1 hour]
  • Functionality of the lower limb [Time frame: 1 hour]

Eligibility criteria

Inclusion criteria

  • Adults aged 18-65
  • Runners with at least one year of regular practice.
  • Must not have suffered any ligament, bone, tendon, or muscle injury in the lower limb or lumbar region during the last year.

Exclusion criteria

  • History of lower limb surgery, rheumatic or neuromuscular diseases or pregnancy
  • Contraindication for radiofrecuency treatment.
  • Athletes with visual, auditory, or any other impairment that may affect their cognitive ability to understand the test.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Health services research

Study locations

Spain · 1 center
  • Clínica Gómez Requena — Vélez-Málaga

Identifiers

NCT: NCT07648199 · 37-2026-H

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗